0 Commentaires
0 Parts
168 Vue
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Blogs
-
Forums
-
Connectez-vous pour aimer, partager et commenter!
-
Global Oncology Drug Market Insights: Opportunities and ForecastsOncology Drugs Market: Driving Innovation in the Global Fight Against Cancer Cancer continues to be one of the leading causes of death worldwide, placing immense pressure on healthcare systems and driving the need for more effective treatments. As a result, the global oncology drugs market has become one of the fastest-growing segments of the pharmaceutical industry. With...0 Commentaires 0 Parts 780 Vue
-
Global Oncology Drug Market Insights: Opportunities and ForecastsOncology Drugs Market: Driving Innovation in the Global Fight Against Cancer Cancer continues to be one of the leading causes of death worldwide, placing immense pressure on healthcare systems and driving the need for more effective treatments. As a result, the global oncology drugs market has become one of the fastest-growing segments of the pharmaceutical industry. With...0 Commentaires 0 Parts 818 Vue
-
Growing Oncology Drug Development Driving the High Potency Active Pharmaceutical Ingredients MarketModern medicine increasingly relies on powerful therapies that work at extremely small doses. Many breakthrough drugs for cancer, hormonal disorders, and targeted therapies depend on compounds that are highly potent yet precisely controlled. These substances are known as High Potency Active Pharmaceutical Ingredients (HPAPIs). The HP (High Potency) Active Pharmaceutical...0 Commentaires 0 Parts 593 Vue
-
Long-Acting Injectable Oncology Drug Market Segmentation & Forecast, Share, SizeFuture of Executive Summary Long-Acting Injectable Oncology Drug Market Market: Size and Share Dynamics The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. A DBMR team of experts and professionals from a...0 Commentaires 0 Parts 491 Vue
-
Long-Acting Injectable Oncology Drug Market Size, Share, Segments and TrendExecutive Summary Long-Acting Injectable Oncology Drug Market Growth Trends and Share Breakdown The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period. This global Long-Acting Injectable Oncology Drug Market...0 Commentaires 0 Parts 201 Vue
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentaires 0 Parts 147 Vue
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commentaires 0 Parts 35 Vue
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Commentaires 0 Parts 4 Vue
-
Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...0 Commentaires 0 Parts 201 Vue
-
High Potency Active Pharmaceutical Ingredients Market to Reach USD 66.38 Billion by 2033, Growing at 9.37% CAGRMarket Overview The global high potency active pharmaceutical ingredients market size was valued at USD 29.64 billion in 2024 and is projected to grow from USD 32.42 billion in 2025 to reach USD 66.38 billion in 2033, growing at a CAGR of 9.37% during the forecast period (2025–2033). The global High Potency Active Pharmaceutical Ingredients market...0 Commentaires 0 Parts 3KB Vue
© 2026 Khajiit Nation
French
French
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek